Invention Publication
- Patent Title: IMIDAZOPYRIDAZINE DERIVATIVES AS IL-17 MODULATORS
-
Application No.: US18267235Application Date: 2021-12-06
-
Publication No.: US20240140951A1Publication Date: 2024-05-02
- Inventor: Gareth Neil Brace , Shuyu Chu , Anne Marie Foley , James Andrew Johnson , Timothy John Norman , Joanna Rachel Quincey , James Thomas Reuberson , Robert Straker , Robert James Townsend
- Applicant: UCB Biopharma SRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SRL
- Current Assignee: UCB Biopharma SRL
- Current Assignee Address: BE Brussels
- Priority: GB 2019702.6 2020.12.14 GB 2109583.1 2021.07.02
- International Application: PCT/EP2021/084448 2021.12.06
- Date entered country: 2023-06-14
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P29/00 ; C07D519/00
Abstract:
A series of substituted imidazo[1,2-b]pyridazine derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.
Information query
